4-56467655-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_006947.4(SRP72):āc.20G>Cā(p.Gly7Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00137 in 1,561,500 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. G7G) has been classified as Benign.
Frequency
Consequence
NM_006947.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRP72 | NM_006947.4 | c.20G>C | p.Gly7Ala | missense_variant | 1/19 | ENST00000642900.1 | NP_008878.3 | |
SRP72 | NM_001267722.2 | c.20G>C | p.Gly7Ala | missense_variant | 1/17 | NP_001254651.1 | ||
SRP72 | XM_024454192.2 | c.20G>C | p.Gly7Ala | missense_variant | 1/17 | XP_024309960.1 | ||
SRP72 | NR_151856.2 | n.39G>C | non_coding_transcript_exon_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRP72 | ENST00000642900.1 | c.20G>C | p.Gly7Ala | missense_variant | 1/19 | NM_006947.4 | ENSP00000495128 | P1 | ||
SRP72 | ENST00000510663.6 | c.20G>C | p.Gly7Ala | missense_variant | 1/17 | 1 | ENSP00000424576 | |||
SRP72 | ENST00000504757.2 | c.20G>C | p.Gly7Ala | missense_variant | 1/5 | 2 | ENSP00000473576 |
Frequencies
GnomAD3 genomes AF: 0.00729 AC: 1109AN: 152136Hom.: 20 Cov.: 31
GnomAD3 exomes AF: 0.00163 AC: 326AN: 199632Hom.: 5 AF XY: 0.00119 AC XY: 132AN XY: 110750
GnomAD4 exome AF: 0.000731 AC: 1030AN: 1409246Hom.: 12 Cov.: 30 AF XY: 0.000650 AC XY: 455AN XY: 699876
GnomAD4 genome AF: 0.00730 AC: 1111AN: 152254Hom.: 20 Cov.: 31 AF XY: 0.00692 AC XY: 515AN XY: 74440
ClinVar
Submissions by phenotype
not provided Benign:5
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The SRP72 p.Gly7Ala variant was not identified in the literature or in the Cosmic database but was identified in dbSNP (ID: rs139502866), ClinVar (reported benign and likely benign) and LOVD 3.0. The variant was identified in control databases in 547 of 230982 chromosomes (8 homozygous) at a frequency of 0.002368 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 481 of 19916 chromosomes (freq: 0.02415), Latino in 46 of 25576 chromosomes (freq: 0.001799), Other in 6 of 5494 chromosomes (freq: 0.001092), South Asian in 3 of 25530 chromosomes (freq: 0.000118), European (non-Finnish) in 11 of 108258 chromosomes (freq: 0.000102), but was not observed in the Ashkenazi Jewish, East Asian, and European (Finnish) populations. The p.Gly7 residue is conserved in mammals but not in more distantly related organisms however four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, and BLOSUM) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Feb 08, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 08, 2021 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 09, 2017 | - - |
Autosomal dominant aplasia and myelodysplasia Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at